Thyrocare Promoter Docon Technologies Releases Shares from Pledge

Docon Technologies Pvt Ltd, a promoter of Thyrocare Technologies Ltd, has announced the release of a pledge on 7,94,69,696 equity shares. This release is a consequence of the full redemption and repayment of Non-Convertible Debentures (NCDs) issued by API Holdings Limited, the ultimate holding company. The NCDs, with an outstanding principal of INR 10,500 million, were fully repaid by API Holdings on August 14, 2026. Consequently, the shares pledged by Docon Technologies are now free from any encumbrance, signifying that the promoter's entire shareholding in Thyrocare is unencumbered.